Food and Drug Administration (FDA) defines medical laser systems as devices that are utilized focused light sources for treating or removing tissues. With the proper utility, medical laser systems allow the surgeon to accomplish more complex tasks, reduce blood loss, decrease postoperative discomfort, reduce the chances of wound infections, and better wound healing. Furthermore, medical laser systems use non-ionizing radiation, and so it does not have the same long-term risks as x-rays or other types of ionizing radiation.
Lumenis Be Ltd. And BIOLASE, Inc.- Notable Market Players in Medical Laser Systems Market
The medical laser systems market is majorly comprised of top players involving Lumenis Be Ltd., Ellex Medical Laser (Noval Eye Medical), Koninklijke Philips N.V., BIOLASE, Inc., BIOLASE, Inc., Bausch Health Companies Inc., Alcon Inc., Iridex Corporation, Candela Medical, Atrivion, Inc.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the medical laser systems market:
Year News
November-2021 Royal Philips announced the North American debut of new Nexcimer laser system. The company has presented and showcased its product at TCT 2021, which was held in Florida. Nexcimer laser system is now available for peripheral and coronary atherectomy and lead extraction procedures.
November-2021 BIOLASE, Inc. the global leader in dental lasers, today announced that it has launched the Epic Hygiene Academy, bringing together leaders in the dental hygiene profession to provide improved continuing education and support the delivery of superior patient care through laser technology.
July-2021 Lumenis announced the launch of a comprehensive global educational platform called MOSES HoLEP University that will enable urologists to offer their patients holmium laser enucleation of the prostate (HoLEP) with MOSES, the gold-standard treatment for enlarged prostate (benign prostatic hyperplasia, or BPH).
May-2021 BIOLASE, Inc. the global leader in dental lasers, announced its Waterlase Pediatric Dental Academy (WPDA), for Waterlase pediatric dentists. The WPDA will provide clinicians with an immersive training experience through peer-led learning, best practice sharing and on-going mentorship, to ensure optimal integration of Waterlase technology into clinical practices.
March-2021 Bausch Health Companies Inc. and its Solta Medical business announced the U.S. launch of the Clear + Brilliant Touch laser. The Clear + Brilliant Touch laser delivers a customized and more comprehensive treatment protocol by providing patients of all ages and skin types the benefits of two wavelengths. By seamlessly switching between two wavelengths with the Original and Perméa handpieces, physicians can now more easily deliver a more complete treatment during a single appointment.
January-2022 CryoLife, Inc. announced that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the word’s “aorta”, “innovation”, and “vision”, the company’s new name and brand reflect its evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease. In conjunction with these changes, effective January 24, 2022, the company will also change its ticker symbol on the New York Stock Exchange to “AORT” from “CRY.”
March-2021 Boston Scientific announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis LTD., a privately held company that develops and commercializes energy-based medical solutions.
March-2021 Iridex Corporation has completed the previously announced transaction with Topcon Corporation. Under the terms of the agreements, Topcon Corporation and its affiliates have completed the $10 million equity investment in Iridex and the purchase of exclusive distribution rights to the Iridex products in Asia Pacific and key EMEA regions, and Iridex has completed the purchase of assets related to PASCAL laser products.
June-2020 Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions, via the financial holding company Lumibird Medical. The purchase includes the Ellex brand name, its R&D and production site based in Adelaide and its subsidiaries based in Australia, Japan, the United States, France and Germany.
